Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma

被引：5
|
作者：
Boidot, Romain [1 ,4 ]
Vegran, Frederique [1 ,4 ]
Soubeyrand, Marie-Sophie [2 ]
Fumoleau, Pierre [3 ]
Coudert, Bruno [3 ]
Lizard-Nacol, Sarab [1 ,4 ]
机构：
[1] IFR Sante STIC, Mol Genet Lab, Ctr Georges Francois Leclerc, F-21034 Dijon, France
[2] IFR Sante STIC, Pathol Lab, F-21034 Dijon, France
[3] IFR Sante STIC, Dept Oncol, F-21034 Dijon, France
[4] IFR Sante STIC, UMR, INSERM, U866, F-21034 Dijon, France
来源：
CANCER INVESTIGATION | 2009年 / 27卷 / 05期
关键词：
Gene expression; Apoptosis; Cell cycle; Stress; Neoadjuvant chemotherapy; Breast cancer; COMPLETE PATHOLOGICAL RESPONSE; CANCER; DOCETAXEL; PROFILES; DOXORUBICIN; EPIRUBICIN; MICROARRAYS; PREDICTION; APOPTOSIS; TUMORS;
D O I：
10.1080/07357900802298096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this study, we performed a screening of 266 gene expressions in breast carcinomas and carried out correlations with histological response to either FEC-100 (fluorouracil-epirubicin-cyclophosphamide; n = 16) or Tax-Epi (docetaxel-epirubicin; n = 12) treatment. Gene expression in biopsies obtained before and after one course of chemotherapy was analyzed. Expression of specific genes was significantly changed after one course of chemotherapy, particularly for Tax-Epi treatment. Comparison with histological response for both treatments revealed that only good responders exhibited changes in gene-expression profile. These results agree that expression of different genes changes in response to anthracycline-based neoadjuvant chemotherapy and show, for the first time, that response to docetaxel-based treatment implied also changes in gene-expression profile.
引用
收藏
页码：521 / 528
页数：8
相关论文
共 50 条
  • [31] Global gene expression changes during neoadjuvant chemotherapy for human breast cancer
    Buchholz, TA
    Stivers, DN
    Stec, J
    Ayers, M
    Clark, E
    Bolt, A
    Sahin, AA
    Symmans, WF
    Hess, KR
    Kuerer, HM
    Valero, V
    Hortobagyi, GN
    Pusztai, L
    CANCER JOURNAL, 2002, 8 (06): : 461 - 468
  • [32] Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
    Lee, Ho-Chang
    Ko, Hyoungsuk
    Seol, Hyesil
    Noh, Dong-Young
    Han, Wonshik
    Kim, Tae-You
    Im, Seock-Ah
    Park, In Ae
    JOURNAL OF BREAST CANCER, 2013, 16 (04) : 395 - 403
  • [33] A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response
    Zheng, Yi
    Li, Shuai
    Boohaker, Rebecca J.
    Liu, Xinli
    Zhu, Yufen
    Zhai, Lili
    Li, Huilan
    Gu, Feng
    Fan, Yu
    Lang, Ronggang
    Liu, Fangfang
    Qian, Xiaolong
    Xu, Bo
    Fu, Li
    JOURNAL OF CANCER, 2015, 6 (07): : 671 - 677
  • [34] Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer
    Karakas, Cansu
    Francis, Ashleigh M.
    Ha, Min Jin
    Wingate, Hannah F.
    Meena, Richard A.
    Yi, Min
    Rasaputra, Komal S.
    Barrera, Angelica M. Gutierrez
    Arun, Banu
    Do, Kim-Anh
    Sahin, Aysegul
    Keyomarsi, Khandan
    Hunt, Kelly K.
    ANNALS OF SURGERY, 2021, 274 (02) : E150 - E159
  • [35] P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Vishnukumar, S.
    Umamaheswaran, G.
    Anichavezhi, D.
    Indumathy, S.
    Adithan, C.
    Srinivasan, K.
    Kadambari, D.
    INDIAN JOURNAL OF CANCER, 2013, 50 (03) : 195 - 199
  • [36] Predictive factors of response to anthracylines neoadjuvant chemotherapy in breast cancer
    Bensouda, Y.
    Ismaili, N.
    Ahbeddou, N.
    El Hassani, K.
    Chenna, M.
    Sbitti, Y.
    Boutayeb, S.
    Errihani, H.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (02): : 81 - 86
  • [37] Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer
    Gebreamlak, Estifanos P.
    Tse, Gary M. K.
    Niu, Yun
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 222 - 226
  • [38] Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer
    Wei, Siwei
    Liu, Lingyan
    Zhang, Jian
    Bowers, Jeremiah
    Gowda, G. A. Nagana
    Seeger, Harald
    Fehm, Tanja
    Neubauer, Hans J.
    Vogel, Ulrich
    Clare, Susan E.
    Raftery, Daniel
    MOLECULAR ONCOLOGY, 2013, 7 (03) : 297 - 307
  • [39] Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer
    Hayashi, Mitsuhiro
    Yamamoto, Yutaka
    Iwase, Hirotaka
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [40] Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Rojo, Federico
    A'Hern, Roger
    Villena, Nadia
    Salter, Janine
    Maria Corominas, Josep
    Servitja, Sonia
    Smith, Ian E.
    Rovira, Ana
    Reis-Filho, Jorge S.
    Dowsett, Mitchell
    Albanell, Joan
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (02) : 130 - 135
12345